ADIPOQ and rheumatoid arthritis: These observations diverge from previous findings in healthy cells [253,254], suggesting that the chronic inflammatory environment in RA alters the typical physiological response to adiponectin [255], shifting from anti-osteoclastogenic to pathologically pro-resorptive.